Table of Contents Table of Contents
Previous Page  58 / 146 Next Page
Information
Show Menu
Previous Page 58 / 146 Next Page
Page Background

A.178

THE INSIDE PROJECT FOR THE ON-LINE VERIFICATION OF

HADRONTHERAPY TREATMENTS: TEST RESULTS WITH A CLINICAL

PROTON BEAM

G. Pirrone

*

, M.A. Piliero.

Department of Physics, University of Pisa and INFN

sezione di Pisa, Pisa, Italy

Introduction:

Particle therapy (PT) is a promising radiotherapy tech-

nique because it offers the possibility to deliver high dose in well-defined

volumes. Treatment monitoring in PT is one of the key issues for treat-

ment quality assessment. A bimodal in-beam monitoring system for the

hadrontherapy treatments of the head and neck tumors is underway within

the INSIDE project. It is based on the detection of both the prompt radia-

tion and the back-to-back annihilation photons created during the irradiation

of the patient. In this work we present the results obtained with the first

prototype of the PET system during the irradiation of a PMMA phantom

with a 72 MeV proton beam. The irradiation was performed at the CNAO

hadrontherapy facility.

Methods and materials

: The PET prototype is based on two planar detec-

tors, each composed of a pixelated LFS scintillator matrix, with 16

×

16 pixels

of 3.2 mm pitch coupled one-to-one to a matrix of multi-pixel photon-

counter array. Each detector is connected to 4 64-channel ASICs managed

by an FPGA-based read-out system. To test our system a PMMA phantom

was irradiated with a 72 MeV proton beam and the image of the β

+

ac-

tivity distribution was calculated through an MLEM reconstruction algorithm.

Results:

The pulsed time structure of the radiation beam was easily re-

constructed and the in-spill coincidence data could be distinguished from

the inter-spill data. The inter-spill activity profile matched the profile cal-

culated with the Monte Carlo simulations. The in-spill activity image was

noisier because of higher number of random coincidences and the anni-

hilation due to the pair production of the high energy prompt photons;

however, the activity profile was still correlated with the irradiated volume.

Conclusions

: The results obtained with the PET prototype were very prom-

ising. Activity spatial distribution images were reconstructed from both in-

spill and inter-spill data. This makes the system suitable for the monitoring

of the treatments at both synchrotron and cyclotron facilities.

http://dx.doi.org/10.1016/j.ejmp.2016.01.182

A.179

USING ANATOMIC AND METABOLIC IMAGING IN STEREOTACTIC RADIO

NEURO-SURGERY TREATMENTS

P. Pisciotta

* , a , b ,

C. Militell

o a ,

L. Rundo

a , c ,

A. Stefan

o a , d ,

G. Russ

o a , e ,

S. Vitabil

e f ,

M.G. Sabin

i e ,

C.D. Arrig

o e ,

F. Marletta

e ,

D.D. Urso

a , b ,

M. Ippolit

o e ,

M. Midir

i f ,

M.C. Gilardi

a .

a

Istituto di Bioimmagini e Fisiologia Molecolare – Consiglio

Nazionale delle Ricerche (IBFM-CNR), Cefalù, Italy;

b

Università degli Studi di

Catania, Catania, Italy;

c

Dipartimento di Informatica, Sistemistica e

Comunicazione (DISCo), Università degli Studi di Milano Bicocca, Milano, Italy;

d

Dipartimento di Ingegneria Chimica, Gestionale, Informatica, Meccanica

(DICGIM), Palermo, Italy;

e

Azienda Ospedaliera per l’Emergenza Cannizzaro,

Catania, Italy;

f

Dipartimento di Biopatologia e Biotecnologie Mediche

(DIBIMED), Università degli Studi di Palermo, Palermo, Italy

Introduction:

This study investigated the impact of biological target volume

(BTV) segmentation, using [11C]-Methionine-PET (MET-PET) images, and

the following co-registration with MR images, used to delineate the gross

target volume (GTV), in stereotactic neuro-surgery therapy. MET-PET di-

agnostic exams provide metabolic information about brain lesions. In this

way, the BTV can be used to modify the GTV in order to treat the entire

cancer region.

Nowadays, GTV is usually delineated using MR images, acquired a few hours

before treatment, using manual segmentation. However, this volume often

does not match entirely with BTV obtained using PET images. For this reason,

metabolic imaging acquires appeal and it could be used to provide addi-

tional information useful for treatment planning. Manual segmentation is

a time-expensive and operator-dependent procedure: stereotactic radio

neuro-surgery treatment effectiveness can be optimized using automatic

methods to support clinicians in the planning phase and to improve treat-

ment response assessment.

Materials and methods:

Two novel semi-automatic and operator-

independent methods have been developed to segment brain lesions from

PET and MR images of 15 patients: the former based on graphs and the

latter based on clustering. The clinical target volume (CTV) is defined using

PET/MR image co-registration.

Results:

The physician was assisted during the treatment-planning phase

with co-registered PET/MR images, in which the lesions have been previ-

ously segmented using the two aforementioned segmentation methods.

The treatment evaluation was executed with international criteria classi-

fication for both MR and PET.

Conclusions:

Both semi-automatic segmentation methods have proved

to be a valid operator-independent instruments to identify the BTV

and the GTV in order to delineate a CTV that include metabolic and

morphologic information and useful for treatment planning and patient

follow-up.

http://dx.doi.org/10.1016/j.ejmp.2016.01.183

A.180

PRELIMINARY DOSIMETRIC STUDY FOR PRECLINICAL SMALL ANIMAL

HADRONTHERAPY

P. Pisciotta

* , a , b , c ,

G. Russo

a , c ,

V. Marchese

a ,

G.A.P. Cirrone

c ,

F. Romano

c ,

D. Lami

a a ,

G. Cuttone

c ,

M.C. Gilardi

a .

a

Istituto di Bioimmagini e Fisiologia

Molecolare, Consiglio Nazionale delle Ricerche (IBFM CNR), Cefalù, PA, Italy;

b

Scuola di Specializzazione in Fisica Medica, Università degli studi di Catania,

Catania, Italy;

c

Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali del

Sud, Catania, Italy

Introduction:

The development of hadrontherapy treatment techniques

evolved dramatically in the last years, producing new technologies giving

the possibility of highly conformal dose approach. In this context, pre-

clinical evaluations and study results are essential. High precision in dose

deposition measure is one of the main requirements to perform success-

ful preclinical studies.

The aim of this study was to perform a proton therapy preclinical study

at INFN-LNS in Catania.

Materials and methods:

The phases followed were: the development a well-

defined dosimetric protocol, in order to achieve a high conformal dose to

the target; the design of a homemade positioning system, in order to guar-

antee a precise and consistent animal setup; the development and the

validation of a custom Geant4 application useful for irradiation treat-

ment planning of small animal. The application permits the reproduction

of CATANA (INFN-LNS) beam line geometry, of hadronic physic processes,

and the implementation of DICOM images as target obtain using a micro-

CT. So, starting from DICOM micro-CT images, our application is able to

reconstruct the real area that must be irradiated.

Results:

A preclinical small animal holder was developed. A treatment sim-

ulation was executed at CATANA facility irradiating a PMMA phantom that

simulates a subcutaneous tumour in mice, using EBT3 Gafchromic films.

The dosimetric results were compared with the simulation ones using

Kolmogorov and gamma index tests.

Conclusion:

An irradiation platform was realised to meet requirements of

mimicking the preclinical application of radiation therapy as closely as pos-

sible and of high conformal dose to the target, avoiding to irradiate the

surrounding healthy tissues. In addition, our Geant4 application has proved

to be a valid instrument to study dose distribution in different phantoms

with very variable geometry. This work lays the foundation to implement

interesting future in vivo studies using small animals.

http://dx.doi.org/10.1016/j.ejmp.2016.01.184

A.181

IN-SILICO IMPLEMENTATION OF MRI-60CO BASED RT: A DOSIMETRICAL

COMPARISON WITH RECTAL CANCER (SIMBAD)

E. Placidi

*

, a ,

N. Dinapoli

b ,

L. Boldrini

b ,

G.C. Mattiucci

b ,

D. Piccari

b ,

Ma Gambacort

a b ,

S. Chiesa

b ,

S. Teodoli

a ,

V. Valentini

b ,

A. Piermattei

a ,

L. Azari

o a .

a

UOC di Fisica Sanitaria, Fondazione Policlinico Universitario A.

Gemelli, Roma, Italy;

b

Divisione di Radioterapia Oncologica, Gemelli-ART,

Fondazione Policlinico Universitario A. Gemelli, Roma, Italy

Introduction:

The ViewRay MRI-Co60 hybrid system (MRIdian®) allows

MRI based targeting, autosegmentation and direct planning for

e53

Abstracts/Physica Medica 32 (2016) e1–e70